Thyroid Cancer

Thyroid Cancer is cancer that forms in the thyroid gland (an organ at the base of the throat that makes hormones that help control heart rate, blood pressure, body temperature, and weight). Four main types of thyroid cancer are papillary, follicular, medullary, and anaplastic thyroid cancer. The four types are based on how the cancer cells look under a microscope.

What is Thyroid Cancer?

Thyroid cancer is a type of cancer involving unregulated cell growth in the thyroid gland, which is located at the base of the neck. It is a rare type of cancer, accounting for approximately 1% of all people diagnosed with cancer.

Thyroid Cancer Symptoms

Thyroid Cancer Treatments

Hürthle Cell Thyroid Cancer

Experts present new research to improve care for head and neck cancers at AHNS 2021

As the international community of experts in head-and-neck cancers gathered virtually last week to share new ideas and treatment strategies at the just-ended American Head & Neck Society (AHNS) 10th International Conference on Head and Neck Cancer, Roswell Park Comprehensive Cancer Center teams are presented new research on both the basic science supporting new treatments as well as opportunities to improve the early and accurate diagnosis of thyroid cancer and other head/neck malignancies.

26 Jul 2021

Researchers propose a new non-invasive method to distinguish thyroid nodules from cancer

A lump in the thyroid gland is called a thyroid nodule, and 5-10% of all thyroid nodules are diagnosed as thyroid cancer.

9 Jul 2021

New statement addresses current controversies and evolving concepts in thyroid cancer care

The American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and Molecular Imaging released a joint statement on three key topics addressing controversies in thyroid cancer care.

25 Jun 2021

Study examines safety of COVID-19 vaccination during lactation

A new preprint, recently released on the medRxiv* server, reports from real life in a cohort of mother-child dyads in Singapore. The mothers were lactating after having received COVID-19 vaccination.

25 Jun 2021

CU Cancer Center secures unique SPORE grant for head and neck cancer research

Research and treatment of head and neck cancers at the University of Colorado Cancer Center reached a new level this month with a highly competitive Specialized Programs of Research Excellence grant from the National Cancer Institute.

21 Jun 2021

Researchers analyze transparency, variation of payer-negotiated prices for thyroid cancer treatment

Hospital price transparency is intended to help inform patients about the cost of services and procedures before they receive them. Since Jan. 1, 2021, hospitals in the U.S. have been required by The Centers for Medicare and Medicaid Services (CMS) to provide pricing information online about items and services.

5 Jun 2021

The LUCA device shows high accuracy in thyroid cancer screening

Thyroid nodules are a common pathology having a prevalence of 19-76% when screened with ultrasound, with higher frequencies in women.

1 Jun 2021

New strategy could increase the effectiveness of chemotherapy treatments

New research led by a team at Massachusetts General Hospital (MGH) points to a promising strategy to boost tumors' intake of cancer drugs, thereby increasing the effectiveness of chemotherapy treatments.

7 May 2021

New device uses harmless light particles for real-time monitoring of newborn babies' brains

An estimated 500,000 babies born around the world each year develop unnecessary brain damage that could be treated if caught in time – but monitoring these infants' delicate brains is extremely difficult.

30 Apr 2021

Researchers map the changing trends of cancer burden worldwide and in China

Cancer is one of the leading causes of mortality worldwide, and the global burden of cancer continues to rise steadily and unchecked.

15 Apr 2021

Exposure to nighttime artificial lights linked with higher risk of thyroid cancer

People living in regions with high levels of outdoor artificial light at night may face a higher risk of developing thyroid cancer.

8 Feb 2021

SU2C announces $3.25 million in grants to find new treatments for head and neck cancers

Stand Up To Cancer today announced $3.25 million in grants from four national nonprofits to fund research to find new treatments for head and neck cancers, which are newly diagnosed in about 65,000 Americans every year.

21 Jan 2021

New computational technique accurately differentiates between data from tumor cells and normal cells

In an effort to address a major challenge when analyzing large single-cell RNA-sequencing datasets, researchers from The University of Texas MD Anderson Cancer Center have developed a new computational technique to accurately differentiate between data from cancer cells and the variety of normal cells found within tumor samples.

18 Jan 2021

Thyroid cancer linked to in-utero exposures, study shows

A recent study by prof. Tone Bjørge, University of Bergen, and her team shows that thyroid cancer is related to in-utero exposures.

5 Jan 2021

Active surveillance could be a viable treatment option for patients with low-risk thyroid cancer

Results from a new study co-led by researchers at Dartmouth's Geisel School of Medicine and the Department of Surgery at Kuma Hospital in Kobe, Japan show that active surveillance can be successfully implemented as a viable treatment option for patients with low-risk thyroid cancer.

8 Dec 2020

Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumours in patients with nonsmall cell lung cancer (NSCLC), with a majority of patients living for more than a year without disease progression.

28 Sep 2020

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, in the majority of participants in the Phase I/II LIBRETTO-001 trial, according to researchers from The University of Texas MD Anderson Cancer Center.

27 Aug 2020

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.

20 Aug 2020

Combination therapy effective for patients with cholangiocarcinoma marked by BRAF mutations

In a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, the combination of dabrafenib, a BRAF inhibitor, and trametinib, a MEK inhibitor, achieved a 51% overall response rate (ORR) in patients with cholangiocarcinoma marked by the BRAF V600E mutation.

18 Aug 2020

Study uses a statistical approach to reveal patterns of cancer incidence

QUT researchers have used nationwide cancer mapping statistics to develop a new mathematical model so health professionals can further question patterns relating to the disease.

13 Aug 2020

Thyroid Cancer

Overview

Thyroid Cancer Symptoms

Thyroid Cancer Treatments

Hürthle Cell Thyroid Cancer

Latest Thyroid Cancer News and Research

Experts present new research to improve care for head and neck cancers at AHNS 2021

Researchers propose a new non-invasive method to distinguish thyroid nodules from cancer

New statement addresses current controversies and evolving concepts in thyroid cancer care

Study examines safety of COVID-19 vaccination during lactation

CU Cancer Center secures unique SPORE grant for head and neck cancer research

Researchers analyze transparency, variation of payer-negotiated prices for thyroid cancer treatment

The LUCA device shows high accuracy in thyroid cancer screening

New strategy could increase the effectiveness of chemotherapy treatments

New device uses harmless light particles for real-time monitoring of newborn babies' brains

Researchers map the changing trends of cancer burden worldwide and in China

Exposure to nighttime artificial lights linked with higher risk of thyroid cancer

SU2C announces $3.25 million in grants to find new treatments for head and neck cancers

New computational technique accurately differentiates between data from tumor cells and normal cells

Thyroid cancer linked to in-utero exposures, study shows

Active surveillance could be a viable treatment option for patients with low-risk thyroid cancer

Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

Sortilin may hold the key to developing more effective treatment for pancreatic cancer

Combination therapy effective for patients with cholangiocarcinoma marked by BRAF mutations

Study uses a statistical approach to reveal patterns of cancer incidence

Increasing your risk of IBD through processed food

World Brain Day 2021: An interview with Professor Alan Thompson

Preventing lethal blood clots

Thyroid Cancer

Overview

Latest Thyroid Cancer News and Research

Newsletters you may be interested in